CRISPR/Cas9 technology replaced exon 6 containing the start codon with a neomycin resistance gene cassette resulting in a 277 bp deletion resulting in a frameshift mutation and premature termination codon at residue 149. Western blot confirmed the absence of the protein in the cochlea. (J:293683)